Use of sanglifehrin in hcv

Details Use of sanglifehrin in hcv Use of sanglifehrin in hcv

A - Human Necessities

61

K

A61K 31/5025 (2006.01) A61P 1/16 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2611151

The present invention discloses the use of a macrolide compound such as a sanglifehrin for the treatment and prevention of hepatitis C and related diseases such as liver fibrosis, liver cirrhosis and hepatocellular carcinoma.

La présente invention a trait à l'utilisation d'un composé de type macrolide tel qu'une sangliféhrine pour le traitement et la prévention de l'hépatite C et de maladies associées telles que la fibrose hépatique, la cirrhose du foie et le carcinome hépatocellulaire.

Affiliated with

Also associated with

Rating

Use of sanglifehrin in hcv does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of sanglifehrin in hcv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sanglifehrin in hcv will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1691004